Gardasil News and Research

RSS
Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.
CDC recommends human papillomavirus virus vaccination

CDC recommends human papillomavirus virus vaccination

Vaccine no replacement for Pap test

Vaccine no replacement for Pap test

FDA approves cervical cancer vaccine

FDA approves cervical cancer vaccine

New era in cancer prevention

New era in cancer prevention

FDA approves Gardasil as a treatment for cervical cancer

FDA approves Gardasil as a treatment for cervical cancer

FDA approval of Gardasil to prevent cervical cancer

FDA approval of Gardasil to prevent cervical cancer

Bill Gates puts his money where his mouth is again

Bill Gates puts his money where his mouth is again

Vaccine against cervical cancer on track for FDA approval

Vaccine against cervical cancer on track for FDA approval

Cervical cancer vaccines in development

Cervical cancer vaccines in development

Good results with cervical cancer vaccine in young girls

Good results with cervical cancer vaccine in young girls

A promising new vaccine against a pre-cancerous cervical virus

A promising new vaccine against a pre-cancerous cervical virus

Cervical cancer vaccine shows promising results but smear tests still vital

Cervical cancer vaccine shows promising results but smear tests still vital

100% efficacy for cervical cancer vaccine

100% efficacy for cervical cancer vaccine

Merck cervical cancer virus vaccine performs well

Merck cervical cancer virus vaccine performs well

Cervical cancer virus vaccine appears very promising

Cervical cancer virus vaccine appears very promising

Race to market cancer vaccine

Race to market cancer vaccine